Evidence map›Paper›PMID 12610094›Full record

ReviewJournal of clinical pathology2003

Burkitt's lymphoma: new insights into molecular pathogenesis.

C Bellan, S Lazzi, G De Falco, A Nyongo, A Giordano, L Leoncini

Abstract readReview
In one paragraph

Review in Journal of clinical pathology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Reticuloendothelial malignancy of head and neck: A comprehensive review.Journal of pharmacy & bioallied sciences · 2015
    Review
  14. Article
  15. Article
  16. Article
  17. Molecular profiling of aggressive lymphomas.Advances in hematology · 2012
    Article
  18. Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cells.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2012
    Article
  19. Expression of JL1 in Burkitt lymphoma is associated with improved overall survival.Virchows Archiv : an international journal of pathology · 2011
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

C BellanInstitute of Pathological Anatomy and Histology, University of Siena, Nuovo Policlinico Le Scotte, Via delle Scotte, 6, 53100 Siena, Italy. leoncinil@unisi.it
S Lazzi
G De Falco
A Nyongo
A Giordano
L Leoncini

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organisation classification reports three subcategories of Burkitt's lymphoma (BL)--endemic, non-endemic, and immunodeficiency associated--proposed to reflect the major clinical and genetic subtypes of this disease. These different types of BL have been reviewed and studied by immunohistochemistry and molecular methods. The results point out the heterogeneity of BL and suggest that AIDS related BL may have a different pathogenesis from that of classic BL.

Indexed as

AdolescentAdultBurkitt LymphomaCell CycleChildChild, PreschoolFemaleHerpesvirus 4, HumanHIV-1HumansInfantLymphoma, AIDS-RelatedMaleMiddle Aged

Identifiers

PMID12610094
PMCPMC1769902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.